That has been my thinking for some time now. Pruri

That has been my thinking for some time now. Prurisol is the most likely candidate for partnership because it is the easiest to value based on the Phase 2 results. I like that the bashers will have no idea if it works or not until unblinded results are released. There is even a slight possibility that data could be released concurrently with a partnership deal.